← Leaderboards
Ivan Diaz
New York University School Of Medicine
$149,711
Attributed
$299,422
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$299,422 · 1
By mechanism
R01$299,422 · 1
Top collaborators
- Michele Santacatterina1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Gira Bhabha$6,214,538
- Leopoldo Nicolas Segal$9,785,416
- Huilin Li$3,763,526
- Kenneth Stapleford$2,390,482
- Yulin Ge$12,393,958
Others in their field
Other Rising Stars on “Antiviral Drug Development”
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Jeff T Hutchins · Inhalon Biopharma, Inc.$10,784,260
- Michael George Natchus · Emory University$10,548,554
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
Research focus
Antiviral Drug DevelopmentAreaClinical TrialsClinical Trials DesignCommunicable DiseasesComplex DataCovid-19Covid-19 PatientCovid-19 TreatmentDesignEmerging Communicable DiseasesEmerging PathogenEnsureExperimental StudyFailureFlexibilityHospitalizationIneffective TherapiesInfectious Diseases ResearchInstructionMethodologyMissionModernizationNational Institute Of Allergy And Infectious Disease